Detalhe da pesquisa
1.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
N Engl J Med
; 386(5): 449-462, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108470
2.
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.
Gastric Cancer
; 26(4): 626-637, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106214
3.
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Lancet
; 398(10302): 759-771, 2021 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454674
4.
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
Oncologist
; 26(9): e1538-e1547, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34037286
5.
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
Gastric Cancer
; 24(4): 970-977, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713215
6.
Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours.
Neuroendocrinology
; 110(5): 413-421, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31437838
7.
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
Neuroendocrinology
; 110(7-8): 688-696, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31639796
8.
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Gastric Cancer
; 23(4): 689-698, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128634
9.
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 420-435, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718072
10.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 392(10142): 123-133, 2018 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880231
11.
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Neuroendocrinology
; 109(2): 100-112, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703770
12.
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(11): 1437-1448, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355453
13.
68Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' Management.
Neuroendocrinology
; 106(2): 128-138, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28399530
14.
Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy.
Acta Oncol
; 57(6): 790-798, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29308947
15.
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Lancet Oncol
; 18(5): 640-653, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28343975
16.
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Lancet Oncol
; 18(3): 357-370, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28163000
17.
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 18(12): 1652-1664, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074099
18.
Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
Acta Oncol
; 56(9): 1224-1232, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28524708
19.
Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer.
Gastric Cancer
; 20(2): 358-367, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27255289
20.
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma.
BMC Cancer
; 16(1): 779, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27724887